A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 645-663

  Munckhof, Wendy J ^a   Lindsay Grayson, M ^a   Turnidge, John D ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; GENTAMICIN; NETILMICIN;

AUDIOMETRY; BACTERIAL INFECTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ELECTRONYSTAGMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NEPHROTOXICITY; OTOTOXICITY; REVIEW; VESTIBULAR DISORDER;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; HEARING; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 9244219626     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.645     Document Type: Review

References (64)

1. Barclay, M. L., Begg, E. J., & Chambers, S. T. (1992). Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrobial Agents and Chemotherapy 36, 1951-7.
2. Bennett, W. M., Plamp, C. E., Gilbert, D. N., Parker, R. A. & Porter, G. A. (1979). The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. Journal of Infectious Diseases 140, 576-80.
3. Berlin, J. A., Laird, N. M., Sacks, H. S., Chalmers, T. C. (1989). A comparison of statistical methods for combining event rates from clinical trials. Statistics in Medicine 8, 141-51.
4. Blaser, J., Stone, B. B., Groner, M. C., Zinner, S. H. (1987). Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy 31, 1054-60.
5. Blaser, J., Stone, B. B., Zinner, S. H. (1985). Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrobial Agents and Chemotherapy 27, 343-9.
6. Brummett, R. E. & Fox, K. E. (1982). Studies of aminoglycoside ototoxicity in animal models. In The Aminoglycosides. Microbiology, Clinical Use and Toxicology (Whelton, A. & Neu, H.C., Eds), pp. 419-551. Marcel Dekker, New York.
7. Bundtzen, R. W., Gerber, A. U., Cohn, D. L. & Craig, W. A. (1981). Postantibiotic suppression of bacterial growth. Reviews of Infectious Diseases 3, 28-37.
8. Carlin, J. B. (1992). Metaanalysis for 2 × 2 tables: a Bayesian approach. Statistics in Medicine 11, 141-158
9. Chalmers, T. C. (1991). Problems induced by meta-analyses. Statistics in Medicine 10, 971-980.
10. Chalmers, T. C., Levin, H., Sacks, H. S., Reitman, D., Berrier, J. & Nagalingam, R. (1987). Meta-analysis of clinical trials as a scientific discipline. 1: control of bias in comparison with large co-operative trials. Statistics in Medicine 6, 315-25.
11. Cohen, B., Saginur, R., Clecner, B., Mendelson, J. & Kavalec, E. (1990). Double-bund comparative trial of once-versus twice-daily netilmicin therapy in severe acute urinary tract infections. Current Therapeutic Research 38, 880-4.
12. Daikos, G. L., Jackson, G. G., Lolans, V. T. & Livermore, D. M. (1990). Adaptive resistance to aminoglycosides from first-exposure down-regulation. Journal of Infectious Diseases 162, 414-20.
13. Daikos, G. L., Lolans, V. T. & Jackson, G. G. (1991). First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrobial Agents and Chemotherapy 35, 117-23.
14. DerSimonian, R. & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-88.
15. de Vries, P. J., Verkooyen, R. P., Leguit, P. & Verburgh, H. A. (1990). Prospective randomised study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections. European Journal of Clinical Microbiology and Infectious Diseases 9, 161-8.
16. Deziel-Evans, L. M., Murphy J. E. & Job M. L. (1986). Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides. Clinical Pharmacy 5, 319-24.
17. Dickersin, K., Min, Y. I. & Meinert, C. L. (1992). Factors influencing the publication of research results: follow-up of applications submitted to two institutional review boards. Journal of the American Medical Association 267, 374-8.
18. Dulon, D., Aurousseau, C., Erre, J. P. & Aran, J. M. (1988). Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the guinea pig. Acta Otolaryngologica 106, 219-25.
19. Elhanan, K., Siplovich, L. & Raz, R. (1995). Gentamicin once-daily versus thrice-daily in children. Journal of Antimicrobial Chemotherapy 35, 327-32.
20. Fan, S. T., Lau, W. Y., Teoh-Chan, C. H., Lau, K. F. & Mauracher, E. H. (1988). Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis. Journal of Antimicrobial Chemotherapy 22, 69-74.
21. Fantin, B. & Carbon, C. (1992). In vivo antibiotic synergism. Contribution of animal models. Antimicrobial Agents & Chemotherapy 36, 907-912.
22. Giamerellou, H., Yiallouros, K., Petrikkos, G., Moschovakis, E., Vavouraki, E. & Voutsinas D. et al. (1991). Comparitive kinetics and efficacy of amikacin adminidtered once or twice daily in the treatment of systemic Gram-negative infections. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 73-9.
23. Gibson, J., Johnson, L., Snowden, L., Joshua, D., Young, G., Macleod, C. et al. (1993). Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial. International Journal of Haematology 58, 63-72.
24. Gilbert, D. N. (1991). Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy 35, 399-405.
25. Giuliano, R. A., Verpooten, G. A., Verbist, L., Wedeen, R. P. & De Broe, M.E. (1986). In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. Journal of Pharmacology and Experimental Therapeutics. 236, 470-5.
26. Hansen, M., Achen, F., Carstensen, C., Coolidge, J., Dahlager, J., Frimodt-Moller, N. et al. (1988). Once versus thrice daily dosing of netilmicin in febrile immunocompromised patients: a randomised controlled study of efficacy and safety. Journal of Drug Development 1, Suppl 3, 119-24.
27. Hollender, L. F., Bahnini, J., De Manzini, N., Lau, W. Y., Fan S. T., Hermansyur, K. et al. (1989). A multicentric study of netilmicin once-daily versus thrice-daily in patients with appendicitis and other intra-abdominal infections. Journal of Antimicrobial Chemotherapy 23, 773-83.
28. Ibrahim, S., Derde, M. P., Kaufman, L., Clerckx-Braun, F., Jacqmin, P. H., Brulein, V. et al. (1990). Safety, pharmacokinetics, and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease. Renal Failure 12, 199-203.
29. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer. (1993). Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine 119, 584-93.
30. Kaloyanides, G. J. & Pastoriza-Munoz, E. (1980). Aminoglycoside nephrotoxicity. Kidney International 18, 571-582.
31. L'Abbe, K. A., Detsky, A. S. & O'Rourke, K. (1987). Meta-analysis in clinical research. Annals of Internal Medicine 107, 224-33.
32. Labovitz, E., Levinson, M. E. & Kaye, D. (1974). Single dose daily gentamicin therapy in urinary tract infection. Antimicrobial Agents and Chemotherapy 6, 465-70.
33. Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W., et al. (1989). Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. Journal of Infectious Diseases 159, 281-92.
34. Leoni, F., Ciolli, S., Pascarella, A., Fanci, R., Caporale, R. & Ferrini, P. R. (1993). Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients. Chemotherapy 39, 147-52.
35. Maller, R., Ahrne, H., Eilard, T., Eriksson, I., Lausen, I., and the Scandanavian Amikacin Once Daily Study Group. (1991). Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Journal of Antimcrobial Chemotherapy 27, (Suppl C), 121-8.
36. Maller, R., Ahrne, H., Holmen, C., Lausen, I., Nilsson, L. E., Smedjegard, J. and the Scandanavian Amikacin Once Daily Study Group. (1993). Once- versus twice-daily amikacin regimen: efficacy and safety in systemic Gram-negative infections. Journal of Antimicrobial Chemotherapy 31, 939-48.
37. Maller, R., Isaksson, B., Nilsson, L. & Soren, L. (1988). A study of amikacin given once versus twice daily in serious infections. Journal of Antimicrobial Chemotherapy 22, 75-79.
38. Mantel, N. & Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22, 719-48.
39. Marik, P., Lipman, J., Kobilski, S. & Scribante, J. (1991). A prospective randomised study comparing once- versus twice-daily amikacin in critically ill adult and paediatric patients. Journal of Antimicrobial Chemotherapy 28, 753-64.
40. Mauracher, E.H., Lau, W.Y., Kartowisastro, H., Ong, K., Genato, U.X., Limson, B. et al. (1989). Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multi-center study in six Asian countries. Clinical Therapeutics 11, 604-13.
41. nd edition. Cambridge. Massachusetts: Cytel Software Corporation, 6.1-6.38
42. Mendes da Costa, P. & Kaufman, L. (1992). Amikacin once daily plus metronidazole versus amikacin twice daily plus metronidazole in colorectal surgery. Hepato-Gastroenterology 39, 350-54.
43. Moore, R. D., Lietman, P. S. & Smith, C. R. (1987). Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. Journal of Infectious Diseases 155, 93-9.
44. Nördstrom, L., Ringberg, H., Cronberg, S., Tjernstrom, O., Walder, M. (1990). Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? Journal of Antimicrobial Chemotherapy 25, 159-73.
45. Parker, S. E. & Davey, P. G. (1990). Pharmacoeconomics of intravenous drug administration. Pharmacoeconomics 2, 103-15.
46. Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D. et al. (1983). Once daily versus continuous aminioglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. Journal of Infectious Diseases 147, 918-32.
47. Prins, J. M., Buller, H. P., Kuijper, E. J., Tange, R, A. & Speelman, P. (1994). Once-daily gentamicin versus once-daily netilmicin in patients with serious infections - a randomised clinical trial. Journal of Antimicrobial Chemotherapy 33, 823-25.
48. Prins, J. M., Buller, H. P., Kuijper, E. J., Tange, R. A. & Speelman, P. (1993). Once versus thrice daily gentamicin in patients with serious infection. Lancet 341, 335-39.
49. Raz, R., Adawi, M. & Romano, S. (1995). Intravenous administration of gentamicin only daily versus thrice daily in adults. European Journal of Clinical Microbiology and Infectious Diseases 14, 88-91.
50. Rozdzinski, E., Kern, W. V., Reichle, A., Moritz, T., Schmeiser, T., Gaus, W. et al. (1993). Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. Journal of Antimicrobial Chemotherapy 31, 585-98.
51. Sturm, A. W. (1989). Netilmicin in the treatment of Gram-negative bacteremia: single daily versus multiple daily dosage. Journal of Infectious Diseases 159, 931-7.
52. Tange, R. A., Conijn, E. A., van Zeijl, L. G., Huizing, E. H. (1982). Pattern of gentamicin-induced cochlear degeneration in the guinea pig. A morphological and electro-physiological study. Archives of Otorhinolaryngology 236, 173-84.
53. ter Braak, E. W., de Vries, P. J., Bouter, P., Van der Vegt, S. G., Dorrestein, G. C., Nortier, J. W. et al. (990). Once-daily dosage regimen for aminoglycoside plus b-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. American Journal of Medicine 89, 58-66.
54. Tran B. H., P., Bernard, P., & Schacht, J. (1986). Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissues and fluids with other organs. Journal of Clinical Investigation 77, 1492-500.
55. Tulkens, P. M. (1991). Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 49-61.
56. Tulkens, P. M., Clerckz-Braun, F., Donnez, J., Irahim, S., Kallay, Z., Delmee, M. et al. (1988). Safety and efficacy of aminoglycosides once-a-day: experimental data and randomised controlled evaluation in patients suffering from pelvic inflammatory disease. Journal of Drug Development 1, Suppl. 3, 71-82.
57. Van der Auwera, P., Meunier, F., Ibrahim, S., Kaufman, L., Derde, M. P., Tulkens, P. M. et al. (1991). Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/ kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection. Antimicrobial Agents and Chemotherapy 35, 640-7.
58. Vanhaeverbeek, M., Siska, G., Douchamps, J. & Herchuelz, A. (1993). Comparison of the efficacy and safety of amikacin once or twice-daily in the treatment of severe gram-negative infections in the elderly. International Journal of Clinical Pharmacology Therapy and Toxicology 31, 153-6.
59. Verpooten, G. A., Giuliano, R. A., Verbist, L., Eestermans, G., & De Broe, M. E. (1989). Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clinical Pharmacology and Therapeutics 45, 22-7.
60. Vigano, A., Principi, N., Brivio, L., Tommasi, P., Stasi, P. & Dalla Villa, A. (1992). Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children. Antimcrobial Agents and Chemotherapy 36, 1499-503.
61. Vogelman, B. & Craig, W. A. (1986). Kinetics of antimicrobial killing. Journal of Pediatrics 108, 835-40.
62. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge J., Ebert S. & Craig, W. A. (1988). Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 158, 831-47.
63. Wilson, A. & Henry, D. A. (1992). Meta-analysis: assessing the quality of published meta-analyses. Medical Journal of Australia 156, 173-87.
64. Zhanel, G. G., Hoban, D. J. & Harding, G. K. M. (1991). The postantibiotic effect: a review of in-vitro and in-vivo data. DICP Annals Pharmacotherapeutics 25, 153-63.